{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:55:41Z","timestamp":1790369741250,"version":"4.1.0"},"reference-count":145,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/2\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ZIAMH002857"],"award-info":[{"award-number":["ZIAMH002857"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The glutamatergic modulator ketamine has created a blueprint for studying novel pharmaceuticals in the field. Recent studies suggest that \u201cclassic\u201d serotonergic psychedelics (SPs) may also have antidepressant efficacy. Both ketamine and SPs appear to produce rapid, sustained antidepressant effects after a transient psychoactive period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This review summarizes areas of overlap between SP and ketamine research and considers the possibility of a common, downstream mechanism of action. The therapeutic relevance of the psychoactive state, overlapping cellular and molecular effects, and overlapping electrophysiological and neuroimaging observations are all reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Taken together, the evidence suggests a potentially shared mechanism wherein both ketamine and SPs may engender rapid neuroplastic effects in a glutamatergic activity-dependent manner. It is postulated that, though distinct, both ketamine and SPs appear to produce acute alterations in cortical network activity that may initially produce psychoactive effects and later produce milder, sustained changes in network efficiency associated with therapeutic response. However, despite some commonalities between the psychoactive component of these pharmacologically distinct therapies\u2014such as engagement of the downstream glutamatergic pathway\u2014the connection between psychoactive impact and antidepressant efficacy remains unclear and requires more rigorous research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Rapid-acting antidepressants currently under investigation may share some downstream pharmacological effects, suggesting that their antidepressant effects may come about via related mechanisms. Given the prototypic nature of ketamine research and recent progress in this area, this platform could be used to investigate entirely new classes of antidepressants with rapid and robust actions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ijnp\/pyaa087","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T15:16:39Z","timestamp":1605539799000},"page":"8-21","source":"Crossref","is-referenced-by-count":102,"title":["Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants"],"prefix":"10.1093","volume":"24","author":[{"given":"Bashkim","family":"Kadriu","sequence":"first","affiliation":[{"name":"Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximillian","family":"Greenwald","sequence":"additional","affiliation":[{"name":"Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioline D","family":"Henter","sequence":"additional","affiliation":[{"name":"Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4194-6172","authenticated-orcid":false,"given":"Jessica R","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kraus","sequence":"additional","affiliation":[{"name":"Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence T","family":"Park","sequence":"additional","affiliation":[{"name":"Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Carlos A","family":"Zarate","sequence":"additional","affiliation":[{"name":"Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,30]]},"reference":[{"key":"2021012009032027100_CIT0001","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/npp.2016.186","article-title":"Ketamine treatment and global brain connectivity in major depression","volume":"42","author":"Abdallah","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"2021012009032027100_CIT0002","first-page":"2470547018796102","article-title":"Ketamine, but not the NMDAR antagonist lanicemine, increases prefrontal global connectivity in depressed patients","volume":"2","author":"Abdallah","year":"2018","journal-title":"Chronic Stress (Thousand Oaks, Calif)"},{"key":"2021012009032027100_CIT0003","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/s41386-018-0136-3","article-title":"The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects","volume":"43","author":"Abdallah","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"2021012009032027100_CIT0004","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jad.2019.11.028","article-title":"Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression","volume":"263","author":"Acevedo-Diaz","year":"2020","journal-title":"J Affect Disord"},{"key":"2021012009032027100_CIT0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0269881119897615","article-title":"Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer","volume":"34","author":"Agin-Liebes","year":"2020","journal-title":"J Psychopharmacol"},{"key":"2021012009032027100_CIT0006","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/bs.pbr.2018.08.009","article-title":"Common neural signatures of psychedelics: frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition","volume":"242","author":"Atasoy","year":"2018","journal-title":"Prog Brain Res"},{"key":"2021012009032027100_CIT0007","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.euroneuro.2019.02.005","article-title":"Anxiety during ketamine infusions is associated with negative treatment responses in major depressive disorder","volume":"29","author":"Aust","year":"2019","journal-title":"Eur Neuropsychopharmacol"},{"key":"2021012009032027100_CIT0008","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"2021012009032027100_CIT0009","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.biopsych.2016.06.012","article-title":"Ketamine and imipramine reverse transcriptional signatures of susceptibility and induce resilience-specific gene expression profiles","volume":"81","author":"Bagot","year":"2017","journal-title":"Biol Psychiatry"},{"key":"2021012009032027100_CIT0010","first-page":"393","article-title":"Classic hallucinogens and mystical experiences: phenomenology and neural correlates.","volume-title":"Behavioral neurobiology of psychedelic drugs","author":"Barrett","year":"2018"},{"key":"2021012009032027100_CIT0011","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1073\/pnas.0700436104","article-title":"Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex","volume":"104","author":"B\u00e9\u00efque","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021012009032027100_CIT0012","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"2021012009032027100_CIT0013","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/ALN.0000000000001275","article-title":"Resting-state network-specific breakdown of functional connectivity during ketamine alteration of consciousness in volunteers","volume":"125","author":"Bonhomme","year":"2016","journal-title":"Anesthesiology"},{"key":"2021012009032027100_CIT0014","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.psyneuen.2010.08.011","article-title":"The double edged sword of neural plasticity: increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover","volume":"36","author":"Branchi","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"2021012009032027100_CIT0015","volume-title":"Rhythms of the brain.","author":"Buzsaki","year":"2011","edition":"1st ed"},{"key":"2021012009032027100_CIT0016","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acschemneuro.8b00134","article-title":"Effects of N, N-dimethyltryptamine on rat behaviors relevant to anxiety and depression","volume":"9","author":"Cameron","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"2021012009032027100_CIT0017","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1073\/pnas.1518377113","article-title":"Neural correlates of the LSD experience revealed by multimodal neuroimaging","volume":"113","author":"Carhart-Harris","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021012009032027100_CIT0018","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"2021012009032027100_CIT0019","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021012009032027100_CIT0020","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol Rev"},{"key":"2021012009032027100_CIT0021","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The therapeutic potential of psychedelic drugs: past, present, and future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"2021012009032027100_CIT0022","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/mp.2017.241","article-title":"Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling","volume":"23","author":"Cavalleri","year":"2018","journal-title":"Mol Psychiatry"},{"key":"2021012009032027100_CIT0023","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.psychres.2018.08.078","article-title":"Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: a randomized, double-blind control study","volume":"269","author":"Chen","year":"2018","journal-title":"Psychiatry Res"},{"key":"2021012009032027100_CIT0024","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/mp.2016.34","article-title":"Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects","volume":"22","author":"Chowdhury","year":"2017","journal-title":"Mol Psychiatry"},{"key":"2021012009032027100_CIT0025","doi-asserted-by":"crossref","first-page":"8988","DOI":"10.1523\/JNEUROSCI.0536-12.2012","article-title":"Global connectivity of prefrontal cortex predicts cognitive control and intelligence","volume":"32","author":"Cole","year":"2012","journal-title":"J Neurosci"},{"key":"2021012009032027100_CIT0026","author":"Compass Pathways","year":"2019"},{"key":"2021012009032027100_CIT0027","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.biopsych.2012.03.029","article-title":"Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression","volume":"72","author":"Cornwell","year":"2012","journal-title":"Biol Psychiatry"},{"key":"2021012009032027100_CIT0028","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3389\/fpsyg.2019.01234","article-title":"Modulation of serum brain-derived neurotrophic factor by a single dose of ayahuasca: observation from a randomized controlled trial","volume":"10","author":"de Almeida","year":"2019","journal-title":"Front Psychol"},{"key":"2021012009032027100_CIT0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2013.06.010","article-title":"Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis","volume":"46","author":"de Bartolomeis","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2021012009032027100_CIT0030","first-page":"242: 69","article-title":"d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: mechanism of action and potential therapeutic applications in mood disorders","volume-title":"Prog Brain Res","author":"De Gregorio","year":"2018"},{"key":"2021012009032027100_CIT0031","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fphar.2016.00348","article-title":"Effects of ketamine on resting-state EEG activity and their relationship to perceptual\/dissociative symptoms in healthy humans","volume":"7","author":"de la Salle","year":"2016","journal-title":"Front Pharmacol"},{"key":"2021012009032027100_CIT0032","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"2021012009032027100_CIT0033","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/17512433.2018.1511424","article-title":"Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews","volume":"11","author":"Dos Santos","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2021012009032027100_CIT0034","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jcpt.12238","article-title":"Rapid-onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression","volume":"40","author":"Drewniany","year":"2015","journal-title":"J Clin Pharm Ther"},{"key":"2021012009032027100_CIT0035","doi-asserted-by":"crossref","first-page":"F1000 Faculty Rev-1659","DOI":"10.12688\/f1000research.14344.1","article-title":"Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide","volume":"7","author":"Duman","year":"2018","journal-title":"F1000Res"},{"key":"2021012009032027100_CIT0036","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat Med"},{"key":"2021012009032027100_CIT0037","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","article-title":"Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments","volume":"102","author":"Duman","year":"2019","journal-title":"Neuron"},{"key":"2021012009032027100_CIT0038","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1017\/S1461145712000545","article-title":"Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder","volume":"16","author":"Duncan","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"2021012009032027100_CIT0039","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.biopsych.2018.01.027","article-title":"Default mode connectivity in major depressive disorder measured up to 10 days after ketamine administration","volume":"84","author":"Evans","year":"2018","journal-title":"Biol Psychiatry"},{"key":"2021012009032027100_CIT0040","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41380-018-0256-5","article-title":"Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)","volume":"25","author":"Fava","year":"2020","journal-title":"Mol Psychiatry"},{"key":"2021012009032027100_CIT0041","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/09540261.2018.1481827","article-title":"Psychedelics as anti-inflammatory agents","volume":"30","author":"Flanagan","year":"2018","journal-title":"Int Rev Psychiatry"},{"key":"2021012009032027100_CIT0042","doi-asserted-by":"crossref","first-page":"101739","DOI":"10.1016\/j.nicl.2019.101739","article-title":"A multicenter study of ketamine effects on functional connectivity: large scale network relationships, hubs and symptom mechanisms","volume":"22","author":"Fleming","year":"2019","journal-title":"Neuroimage Clin"},{"key":"2021012009032027100_CIT0043","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/ijnp\/pyx116","article-title":"Role of 5-HT1A receptor stimulation in the medial prefrontal cortex in the sustained antidepressant effects of ketamine","volume":"21","author":"Fukumoto","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"2021012009032027100_CIT0044","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/s41386-020-0705-0","article-title":"Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT 1A receptor stimulation","volume":"45","author":"Fukumoto","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"2021012009032027100_CIT0045","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1177\/0269881120936486","article-title":"Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca","volume":"34","author":"Galv\u00e3o-Coelho","year":"2020","journal-title":"J Psychopharmacol"},{"key":"2021012009032027100_CIT0046","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","article-title":"Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus","volume":"32","author":"Garcia","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2021012009032027100_CIT0047","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"J Nerv Ment Dis"},{"key":"2021012009032027100_CIT0048","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1176\/ps.2009.60.11.1439","article-title":"What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression","volume":"60","author":"Gaynes","year":"2009","journal-title":"Psychiatr Serv"},{"key":"2021012009032027100_CIT0049","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1172\/JCI130808","article-title":"GABA interneurons are the cellular trigger for ketamine\u2019s rapid antidepressant actions","volume":"130","author":"Gerhard","year":"2020","journal-title":"J Clin Invest"},{"key":"2021012009032027100_CIT0050","doi-asserted-by":"crossref","first-page":"172856","DOI":"10.1016\/j.pbb.2020.172856","article-title":"Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: gamma power and long-term potentiation","volume":"189","author":"Gilbert","year":"2020","journal-title":"Pharmacol Biochem Behav"},{"key":"2021012009032027100_CIT0051","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"2021012009032027100_CIT0052","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"2021012009032027100_CIT0053","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J Psychopharmacol"},{"key":"2021012009032027100_CIT0054","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"2021012009032027100_CIT0055","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.mp.4002075","article-title":"Is it time to reassess the BDNF hypothesis of depression?","volume":"12","author":"Groves","year":"2007","journal-title":"Mol Psychiatry"},{"key":"2021012009032027100_CIT0056","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1017\/S1461145713001119","article-title":"Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression","volume":"17","author":"Haile","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"2021012009032027100_CIT0057","author":"Haridy","year":"2019"},{"key":"2021012009032027100_CIT0058","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/pcn.12902","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective","volume":"73","author":"Hashimoto","year":"2019","journal-title":"Psychiatry Clin Neurosci"},{"key":"2021012009032027100_CIT0059","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuropharm.2018.01.049","article-title":"Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans","volume":"142","author":"Heal","year":"2018","journal-title":"Neuropharmacology"},{"key":"2021012009032027100_CIT0060","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1021\/acschemneuro.9b00493","article-title":"Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression","volume":"11","author":"Hibicke","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"2021012009032027100_CIT0061","doi-asserted-by":"crossref","first-page":"pyv040","DOI":"10.1093\/ijnp\/pyv040","article-title":"Ketamine-induced modulation of the thalamo-cortical network in healthy volunteers as a model for schizophrenia","volume":"18","author":"H\u00f6flich","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"2021012009032027100_CIT0062","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41386-019-0569-3","article-title":"Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects","volume":"45","author":"Holze","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"2021012009032027100_CIT0063","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J Neurosci"},{"key":"2021012009032027100_CIT0064","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J Psychopharmacol"},{"key":"2021012009032027100_CIT0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuropharm.2018.05.012","article-title":"The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act","volume":"142","author":"Johnson","year":"2018","journal-title":"Neuropharmacology"},{"key":"2021012009032027100_CIT0066","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2018.11.010","article-title":"Classic psychedelics: an integrative review of epidemiology, therapeutics, mystical experience, and brain network function","volume":"197","author":"Johnson","year":"2019","journal-title":"Pharmacol Ther"},{"key":"2021012009032027100_CIT0067","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ijnp\/pyy094","article-title":"Glutamatergic neurotransmission: pathway to developing novel rapid-acting antidepressant treatments","volume":"22","author":"Kadriu","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"key":"2021012009032027100_CIT0068","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-017-4820-5","article-title":"The hidden therapist: evidence for a central role of music in psychedelic therapy","volume":"235","author":"Kaelen","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"2021012009032027100_CIT0069","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291716000064","article-title":"Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol Med"},{"key":"2021012009032027100_CIT0070","doi-asserted-by":"crossref","first-page":"84","DOI":"10.24972\/ijts.2014.33.2.84","article-title":"Ketamine psychedelic psychotherapy: focus on its pharmacology, phenomenology, and clinical applications","volume":"33","author":"Kolp","year":"2014","journal-title":"Int J Transpers Stud"},{"key":"2021012009032027100_CIT0071","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1523\/JNEUROSCI.3007-12.2013","article-title":"Activation of serotonin 2A receptors underlies the psilocybin-induced effects on \u03b1 oscillations, N170 visual-evoked potentials, and visual hallucinations","volume":"33","author":"Kometer","year":"2013","journal-title":"J Neurosci"},{"key":"2021012009032027100_CIT0072","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/13651501.2016.1254802","article-title":"Administration of ketamine for unipolar and bipolar depression","volume":"21","author":"Kraus","year":"2017","journal-title":"Int J Psychiatry Clin Pract"},{"key":"2021012009032027100_CIT0073","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.drudis.2019.07.007","article-title":"The influence of ketamine on drug discovery in depression","volume":"24","author":"Kraus","year":"2019","journal-title":"Drug Discov Today"},{"key":"2021012009032027100_CIT0074","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41386-020-0624-0","article-title":"Evaluating global brain connectivity as an imaging marker for depression: influence of preprocessing strategies and placebo-controlled ketamine treatment","volume":"45","author":"Kraus","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"2021012009032027100_CIT0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"2021012009032027100_CIT0076","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.tips.2017.08.003","article-title":"Psychedelic drugs in biomedicine","volume":"38","author":"Kyzar","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"2021012009032027100_CIT0077","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.biopsych.2012.05.031","article-title":"Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients","volume":"72","author":"Laje","year":"2012","journal-title":"Biol Psychiatry"},{"key":"2021012009032027100_CIT0078","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/sj.npp.1300944","article-title":"Hallucinogen-induced UP states in the brain slice of rat prefrontal cortex: role of glutamate spillover and NR2B-NMDA receptors","volume":"31","author":"Lambe","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"2021012009032027100_CIT0079","doi-asserted-by":"crossref","first-page":"e029108","DOI":"10.1136\/bmjopen-2019-029108","article-title":"Effects of ketamine treatment on suicidal ideation: a qualitative study of patients\u2019 accounts following treatment for depression in a UK ketamine clinic","volume":"9","author":"Lascelles","year":"2019","journal-title":"BMJ Open"},{"key":"2021012009032027100_CIT0080","doi-asserted-by":"crossref","first-page":"pyu033","DOI":"10.1093\/ijnp\/pyu033","article-title":"BDNF release is required for the behavioral actions of ketamine","volume":"18","author":"Lepack","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"2021012009032027100_CIT0081","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/cns.12998","article-title":"A brain network model for depression: from symptom understanding to disease intervention","volume":"24","author":"Li","year":"2018","journal-title":"CNS Neurosci Ther"},{"key":"2021012009032027100_CIT0082","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuroimage.2019.03.076","article-title":"Cortical dynamics during psychedelic and anesthetized states induced by ketamine","volume":"196","author":"Li","year":"2019","journal-title":"Neuroimage"},{"key":"2021012009032027100_CIT0083","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"2021012009032027100_CIT0084","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fnmol.2018.00312","article-title":"A single dose of 5-MeO-DMT stimulates cell proliferation, neuronal survivability, morphological and functional changes in adult mice ventral dentate gyrus","volume":"11","author":"Lima da Cruz","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"2021012009032027100_CIT0085","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.biopsych.2011.09.030","article-title":"Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex","volume":"71","author":"Liu","year":"2012","journal-title":"Biol Psychiatry"},{"key":"2021012009032027100_CIT0086","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/hbm.24895","article-title":"Modulation of amygdala reactivity following rapidly acting interventions for major depression","volume":"41","author":"Loureiro","year":"2020","journal-title":"Hum Brain Mapp"},{"key":"2021012009032027100_CIT0087","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep"},{"key":"2021012009032027100_CIT0088","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.4088\/JCP.08m04659","article-title":"Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist","volume":"70","author":"Machado-Vieira","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"2021012009032027100_CIT0089","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol Psychiatry"},{"key":"2021012009032027100_CIT0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/7854_2017_480","article-title":"Interactions of hallucinogens with the glutamatergic system: permissive network effects mediated through cortical layer V pyramidal neurons","volume":"36","author":"Marek","year":"2018","journal-title":"Curr Top Behav Neurosci"},{"key":"2021012009032027100_CIT0091","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2014.03.013","article-title":"Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia","volume":"83","author":"Martin","year":"2014","journal-title":"Neuropharmacology"},{"key":"2021012009032027100_CIT0092","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ebiom.2016.08.049","article-title":"Psychedelics recruit multiple cellular types and produce complex transcriptional responses within the brain","volume":"11","author":"Martin","year":"2016","journal-title":"Ebiomedicine"},{"key":"2021012009032027100_CIT0093","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/7854_2017_479","article-title":"The effects of hallucinogens on gene expression.","volume-title":"Behavioral neurobiology of psychedelic drugs. current topics in behavioral neurosciences","author":"Martin","year":"2017"},{"key":"2021012009032027100_CIT0094","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","article-title":"Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin","volume":"45","author":"Mason","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"2021012009032027100_CIT0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jad.2019.12.023","article-title":"The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: a systematic review","volume":"264","author":"Mathai","year":"2020","journal-title":"J Affect Disord"},{"key":"2021012009032027100_CIT0096","first-page":"283","article-title":"New world tryptamine hallucinogens and the neuroscience of ayahuasca.","volume-title":"Behavioral Neurobiology of Psychedelic Drugs","author":"McKenna","year":"2018"},{"key":"2021012009032027100_CIT0097","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0269881119895520","article-title":"Therapeutic mechanisms of psilocybin: changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression","volume":"34","author":"Mertens","year":"2020","journal-title":"J Psychopharmacol"},{"key":"2021012009032027100_CIT0098","doi-asserted-by":"crossref","first-page":"eaat8078","DOI":"10.1126\/science.aat8078","article-title":"Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation","volume":"364","author":"Moda-Sava","year":"2019","journal-title":"Science"},{"key":"2021012009032027100_CIT0099","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J Neurosci"},{"key":"2021012009032027100_CIT0100","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.nicl.2018.05.037","article-title":"Pharmacological fMRI: Effects of subanesthetic ketamine on resting-state functional connectivity in the default mode network, salience network, dorsal attention network and executive control network","volume":"19","author":"Mueller","year":"2018","journal-title":"Neuroimage Clin"},{"key":"2021012009032027100_CIT0101","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol Psychiatry"},{"key":"2021012009032027100_CIT0102","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.brainres.2004.07.044","article-title":"Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex","volume":"1023","author":"Muschamp","year":"2004","journal-title":"Brain Res"},{"key":"2021012009032027100_CIT0103","doi-asserted-by":"crossref","first-page":"15171","DOI":"10.1523\/JNEUROSCI.2063-13.2013","article-title":"Broadband cortical desynchronization underlies the human psychedelic state","volume":"33","author":"Muthukumaraswamy","year":"2013","journal-title":"J Neurosci"},{"key":"2021012009032027100_CIT0104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jad.2019.07.076","article-title":"Classical psychedelics for the treatment of depression and anxiety: a systematic review","volume":"258","author":"Muttoni","year":"2019","journal-title":"J Affect Disord"},{"key":"2021012009032027100_CIT0105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0169-328X(03)00029-9","article-title":"Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration","volume":"111","author":"Nichols","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"2021012009032027100_CIT0106","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0893-133X(01)00405-5","article-title":"A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain","volume":"26","author":"Nichols","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"2021012009032027100_CIT0107","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol Rev"},{"key":"2021012009032027100_CIT0108","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pscychresns.2018.09.001","article-title":"Synaptic potentiation and rapid antidepressant response to ketamine in treatment-resistant major depression: a replication study","volume":"283","author":"Nugent","year":"2019","journal-title":"Psychiatry Res Neuroimaging"},{"key":"2021012009032027100_CIT0109","doi-asserted-by":"crossref","first-page":"1179069518800508","DOI":"10.1177\/1179069518800508","article-title":"Psychoplastogens: a promising class of plasticity-promoting neurotherapeutics","volume":"12","author":"Olson","year":"2018","journal-title":"J Exp Neurosci"},{"key":"2021012009032027100_CIT0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1590\/1516-4446-2014-1496","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report","volume":"37","author":"Os\u00f3rio","year":"2015","journal-title":"Braz J Psychiatr"},{"key":"2021012009032027100_CIT0111","doi-asserted-by":"crossref","first-page":"e0118143","DOI":"10.1371\/journal.pone.0118143","article-title":"The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network","volume":"10","author":"Palhano-Fontes","year":"2015","journal-title":"Plos One"},{"key":"2021012009032027100_CIT0112","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol Med"},{"key":"2021012009032027100_CIT0113","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neuroimage.2019.06.053","article-title":"Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives","volume":"200","author":"Pallavicini","year":"2019","journal-title":"Neuroimage"},{"key":"2021012009032027100_CIT0114","doi-asserted-by":"crossref","first-page":"e35082","DOI":"10.7554\/eLife.35082","article-title":"Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor","volume":"7","author":"Preller","year":"2018","journal-title":"eLife"},{"key":"2021012009032027100_CIT0115","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/cercor\/13.8.870","article-title":"In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents","volume":"13","author":"Puig","year":"2003","journal-title":"Cereb Cortex"},{"key":"2021012009032027100_CIT0116","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.npp.1301057","article-title":"Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens","volume":"32","author":"Razoux","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"2021012009032027100_CIT0117","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.nicl.2018.07.006","article-title":"Ketamine normalizes brain activity during emotionally valenced attentional processing in depression","volume":"20","author":"Reed","year":"2018","journal-title":"Neuroimage Clin"},{"key":"2021012009032027100_CIT0118","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and psychedelic-assisted psychotherapy","volume":"177","author":"Reiff","year":"2020","journal-title":"Am J Psychiatry"},{"key":"2021012009032027100_CIT0119","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2014.10.022","article-title":"Ketamine ameliorates depressive-like behaviors and immune alterations in adult rats following maternal deprivation","volume":"584","author":"R\u00e9us","year":"2015","journal-title":"Neurosci Lett"},{"key":"2021012009032027100_CIT0120","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front Pharmacol"},{"key":"2021012009032027100_CIT0121","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J Psychopharmacol"},{"key":"2021012009032027100_CIT0122","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2017.12.040","article-title":"Psychiatry and the psychedelic drugs. Past, present and future","volume":"142","author":"Rucker","year":"2018","journal-title":"Neuropharmacology"},{"key":"2021012009032027100_CIT0123","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"key":"2021012009032027100_CIT0124","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/JCP.0000000000000436","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT Study","volume":"36","author":"Sanches","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"2021012009032027100_CIT0125","doi-asserted-by":"crossref","first-page":"46421","DOI":"10.1038\/srep46421","article-title":"Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin","volume":"7","author":"Schartner","year":"2017","journal-title":"Sci Rep"},{"key":"2021012009032027100_CIT0126","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1176\/appi.ajp.2020.20030272","article-title":"Some comments on psychedelic research","volume":"177","author":"Schatzberg","year":"2020","journal-title":"Am J Psychiatry"},{"key":"2021012009032027100_CIT0127","doi-asserted-by":"crossref","first-page":"e0137202","DOI":"10.1371\/journal.pone.0137202","article-title":"Acute biphasic effects of ayahuasca","volume":"10","author":"Schenberg","year":"2015","journal-title":"Plos One"},{"key":"2021012009032027100_CIT0128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(03)00547-0","article-title":"The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats","volume":"346","author":"Scruggs","year":"2003","journal-title":"Neurosci Lett"},{"key":"2021012009032027100_CIT0129","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejphar.2017.09.029","article-title":"Ketamine and aminoguanidine differentially affect Bdnf and Mtor gene expression in the prefrontal cortex of adult male rats","volume":"815","author":"Silva Pereira","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"2021012009032027100_CIT0130","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1002\/hbm.22562","article-title":"Enhanced repertoire of brain dynamical states during the psychedelic experience","volume":"35","author":"Tagliazucchi","year":"2014","journal-title":"Hum Brain Mapp"},{"key":"2021012009032027100_CIT0131","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.1007\/s12035-019-1613-3","article-title":"S-Ketamine reverses hippocampal dendritic spine deficits in flinders sensitive line rats within 1 h of administration","volume":"56","author":"Treccani","year":"2019","journal-title":"Mol Neurobiol"},{"key":"2021012009032027100_CIT0132","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00213-019-05236-w","article-title":"A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms","volume":"236","author":"Uthaug","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"2021012009032027100_CIT0133","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","article-title":"5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex","volume":"17","author":"Vaidya","year":"1997","journal-title":"J Neurosci"},{"key":"2021012009032027100_CIT0134","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.euroneuro.2016.03.012","article-title":"Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans","volume":"26","author":"Valle","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"2021012009032027100_CIT0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jad.2017.09.023","article-title":"Acute psychoactive effects of intravenous ketamine during treatment of mood disorders: analysis of the Clinician Administered Dissociative State Scale","volume":"227","author":"van Schalkwyk","year":"2018","journal-title":"J Affect Disord"},{"key":"2021012009032027100_CIT0136","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bja.2018.03.011","article-title":"Subanaesthetic ketamine and altered states of consciousness in humans","volume":"121","author":"Vlisides","year":"2018","journal-title":"Br J Anaesth"},{"key":"2021012009032027100_CIT0137","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"2021012009032027100_CIT0138","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-clinpsy-032511-143049","article-title":"Default mode network activity and connectivity in psychopathology","volume":"8","author":"Whitfield-Gabrieli","year":"2012","journal-title":"Annu Rev Clin Psychol"},{"key":"2021012009032027100_CIT0139","doi-asserted-by":"crossref","first-page":"E3007","DOI":"10.1073\/pnas.1718883115","article-title":"Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy","volume":"115","author":"Widman","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021012009032027100_CIT0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hbm.24791","article-title":"Ketamine effects on default mode network activity and vigilance: a randomized, placebo-controlled crossover simultaneous fMRI\/EEG study","volume":"41","author":"Zacharias","year":"2020","journal-title":"Hum Brain Mapp"},{"key":"2021012009032027100_CIT0141","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol Psychiatry"},{"key":"2021012009032027100_CIT0142","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1111\/bph.14683","article-title":"(R)-Ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic doses","volume":"176","author":"Zanos","year":"2019","journal-title":"Br J Pharmacol"},{"key":"2021012009032027100_CIT0143","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"2021012009032027100_CIT0144","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine\u2019s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol Psychiatry"},{"key":"2021012009032027100_CIT0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pnpbp.2007.07.009","article-title":"AMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated pre-frontal cortical excitatory synaptic currents and DOI-induced head shakes","volume":"32","author":"Zhang","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/advance-article-pdf\/doi\/10.1093\/ijnp\/pyaa087\/35063507\/pyaa087.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/24\/1\/8\/35927292\/pyaa087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/24\/1\/8\/35927292\/pyaa087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T04:22:10Z","timestamp":1669609330000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/24\/1\/8\/6012768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,30]]},"references-count":145,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,20]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyaa087","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,1]]},"published":{"date-parts":[[2020,11,30]]}}}